111 related articles for article (PubMed ID: 33040630)
1. Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse.
Cho WCS; Tse KP; Ngan RKC; Cheuk W; Ma VWS; Yang YT; Yip TTC; Tan KT; Chen SJ
Expert Rev Mol Diagn; 2020 Nov; 20(11):1149-1159. PubMed ID: 33040630
[TBL] [Abstract][Full Text] [Related]
2. Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.
Fountzilas G; Psyrri A; Giannoulatou E; Tikas I; Manousou K; Rontogianni D; Ciuleanu E; Ciuleanu T; Resiga L; Zaramboukas T; Papadopoulou K; Bobos M; Chrisafi S; Tsolaki E; Markou K; Giotakis E; Koutras A; Psoma E; Kalogera-Fountzila A; Skondra M; Bamia C; Pectasides D; Kotoula V
Int J Cancer; 2018 Jan; 142(1):66-80. PubMed ID: 28857155
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcome-Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma.
Dai W; Chung DL; Chow LK; Yu VZ; Lei LC; Leong MM; Chan CK; Ko JM; Lung ML
Clin Cancer Res; 2020 Dec; 26(24):6494-6504. PubMed ID: 32988965
[TBL] [Abstract][Full Text] [Related]
4. Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-β pathway.
Chung AK; OuYang CN; Liu H; Chao M; Luo JD; Lee CY; Lu YJ; Chung IC; Chen LC; Wu SM; Tsang NM; Chang KP; Hsu CL; Li HP; Chang YS
Cancer Med; 2019 Sep; 8(11):5116-5127. PubMed ID: 31328403
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of a molecular classifier derived from whole-exome sequencing in nasopharyngeal carcinoma.
Wang HY; Li F; Liu N; Liu XY; Yang XH; Guo YM; Bei JX; Zeng YX; Shao JY
Cancer Med; 2019 Jun; 8(6):2705-2716. PubMed ID: 30950204
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
7. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
[TBL] [Abstract][Full Text] [Related]
8. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
10. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: A prospective analysis.
Li YJ; Luo Y; Xie XQ; Li P; Wang F
Radiother Oncol; 2018 Nov; 129(2):396-402. PubMed ID: 30082142
[TBL] [Abstract][Full Text] [Related]
12. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
Tu X; Ren J; Zhao Y
Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the tumor volume reduction rate after neoadjuvant chemotherapy in patients with locoregional advanced nasopharyngeal carcinoma.
Yang H; Liu Y; Zhang R; Ye Y; Chen Q; Qin Q; Huang L; Li X; Cai R; Tang H; Jiang W
Oral Oncol; 2020 Nov; 110():104897. PubMed ID: 32679404
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy.
Liu B; Tan Z; Jiang Y; Chen Y; Chen Y; Ling K
J BUON; 2018; 23(6):1671-1678. PubMed ID: 30610793
[TBL] [Abstract][Full Text] [Related]
18. Management of locally recurrent nasopharyngeal carcinoma.
Lee AWM; Ng WT; Chan JYW; Corry J; Mäkitie A; Mendenhall WM; Rinaldo A; Rodrigo JP; Saba NF; Strojan P; Suárez C; Vermorken JB; Yom SS; Ferlito A
Cancer Treat Rev; 2019 Sep; 79():101890. PubMed ID: 31470314
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
Ali SM; Yao M; Yao J; Wang J; Cheng Y; Schrock AB; Chirn GW; Chen H; Mu S; Gay L; Elvin JA; Suh J; Miller VA; Stephens PJ; Ross JS; Wang K
Cancer; 2017 Sep; 123(18):3628-3637. PubMed ID: 28581676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
